Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose statin versus low-dose statin plus ezetimibe in elderly ASCVD patients
KCT0006265Phase 4Completed
- Sponsor
- Yuhan
- Start
- Jul 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of ulinastatin, ezetimibe in atherosclerotic disease, hypercholesterolemia, sponsored by Yuhan. Started Jul 2021; status: completed.
02
Drugs
ulinastatinezetimibe
03
Conditions
atherosclerotic diseasehypercholesterolemia
Beyond the preview
Go deeper on KCT0006265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006265.